Trial Profile
Annual Study for Serum Collection and Evaluation of Safety and Immunogenicity Among Healthy Children Receiving Influenza Virus Vaccine Fluzone 2004-2005.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Apr 2014
Price :
$35
*
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions
- Sponsors Sanofi Pasteur
- 28 Aug 2009 Primary endpoint amended as reported by ClinicalTrials.gov
- 05 Feb 2009 New trial record